SR 271425

Known as: SR271425 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2013
0119992013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The interest in the synthesis and applications of thioxanthones, dibenzo-gamma-thiopyrones, started in the beginning of the 20th… (More)
Is this relevant?
2009
2009
OBJECTIVES The thioxanthone analog, SR271425, is a novel cytotoxic DNA-interacting agent with broad antitumor activity in… (More)
Is this relevant?
2008
2008
This study was performed to determine the dose limiting toxicity (DLT), the recommended phase II dose and the pharmacokinetic… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2007
2007
OBJECTIVE SR271425 is a thioxanthone cytotoxic drug that induces dose-related cardiac electrophysiologic changes in preclinical… (More)
Is this relevant?
2006
2006
SR271425 is a novel DNA-binding cytotoxic agent with a broad spectrum of antitumor activity in preclinical models,across a… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2001
2001
A simple and reliable HPLC method was developed for the estimation of a new anti-cancer agent that belongs to the thioxanthone… (More)
Is this relevant?
1999
1999
A highly active and broadly active thioxanthone has been identified: N-[[1-[[2-(Diethylamino)ethyl]amino]-7-methoxy-9-oxo-9H… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?